116 related articles for article (PubMed ID: 4406591)
21. [Osseous metastases of neoplasms of the testis. (Clinico-radiological considerations)].
Donati E
Radiobiol Radioter Fis Med; 1969; 24(5):311-23. PubMed ID: 5401553
[No Abstract] [Full Text] [Related]
22. [Thyrocalcitonin and its clinical use].
Migunova NA; Nikiforova NV; Ermolenko VM; Briskin AI
Sov Med; 1973 Apr; 36(4):34-8. PubMed ID: 4588905
[No Abstract] [Full Text] [Related]
23. Control of osteitis deformans using glucagon, calcitonin, and mithramycin.
Condon JR; Surtees J; Robinson V
Postgrad Med J; 1981 Feb; 57(664):84-8. PubMed ID: 6455656
[TBL] [Abstract][Full Text] [Related]
24. Urinary hydroxyproline excretion in early and advanced breast cancer-a sequential study.
Cuschieri A
Br J Surg; 1973 Oct; 60(10):800-3. PubMed ID: 4748385
[No Abstract] [Full Text] [Related]
25. [Plasma free amino acids in malignant bone tumors and in healthy subjects].
Zender R; Courvoisier B
Clin Chim Acta; 1970 Feb; 27(2):259-65. PubMed ID: 5417227
[No Abstract] [Full Text] [Related]
26. [Effect of salmon calcitonin on bone mineral density and calcium-phosphate metabolism in chronic hemodialysis patients with secondary hyperparathyroidism].
Matuszkiewicz-Rowińska J; Niemczyk S; Przedlacki J; Puka J; Switalski M; Ostrowski K
Pol Arch Med Wewn; 2004 Jul; 112(1):797-803. PubMed ID: 15526839
[TBL] [Abstract][Full Text] [Related]
27. Cyproterone acetate in the treatment of advanced carcinoma of the prostate.
Smith RB; Walsh PC; Goodwin WE
J Urol; 1973 Jul; 110(1):106-8. PubMed ID: 4713345
[No Abstract] [Full Text] [Related]
28. Recent advances in thyrocalcitonin research.
Potts JT
Fed Proc; 1970; 29(3):1200-5. PubMed ID: 4910269
[No Abstract] [Full Text] [Related]
29. [Clinical use of calcitonin in the treatment of osseous localizations in breast carcinoma and multiple myeloma].
Di Benedetto G; Corsini G; Puppo F; Zavarise GM
Clin Ter; 1981 Mar; 96(6):605-13. PubMed ID: 7285526
[No Abstract] [Full Text] [Related]
30. Effect of mithramycin on widespread painful bone metastases in cancer of the breast.
Davies J; Trask C; Souhami RL
Cancer Treat Rep; 1979; 63(11-12):1835-8. PubMed ID: 93511
[TBL] [Abstract][Full Text] [Related]
31. Paget's disease of the skull and migraine headache.
Hamilton CR; Quesada O
Johns Hopkins Med J; 1973 Mar; 132(3):179-85. PubMed ID: 4266199
[No Abstract] [Full Text] [Related]
32. Breast cancer in men. Report illustrating the value of endocrine ablation.
Stephens RL; Muggia FM
Am J Med; 1974 Oct; 57(4):679-82. PubMed ID: 4372886
[No Abstract] [Full Text] [Related]
33. Current concepts in the treatment of Ewing's sarcoma.
Weber KL
Expert Rev Anticancer Ther; 2002 Dec; 2(6):687-94. PubMed ID: 12503215
[TBL] [Abstract][Full Text] [Related]
34. Relevance of hydroxyproline excretion to bone metastasis in breast cancer.
Gielen F; Dequeker J; Drochmans A; Wildiers J; Merlevede M
Br J Cancer; 1976 Sep; 34(3):279-85. PubMed ID: 974001
[TBL] [Abstract][Full Text] [Related]
35. Serum calcitonin in patients with osteolytic and osteosclerotic metastases from mammary carcinoma.
Nielsen HE; Gadeberg CC
Acta Radiol Oncol; 1980; 19(5):331-3. PubMed ID: 6259888
[TBL] [Abstract][Full Text] [Related]
36. Free serum hydroxyproline and total urinary hydroxyproline for the detection of skeletal metastasis.
Gasser AB; Depierre D; Mermillod B; Courvoisier B
Br J Cancer; 1982 Mar; 45(3):477-81. PubMed ID: 7041941
[No Abstract] [Full Text] [Related]
37. Paget's disease in a 5-year-old: acute response to human calcitonin.
Woodhouse NJ; Fisher MT; Sigurdsson G; Joplin GF; MacIntyre I
Br Med J; 1972 Nov; 4(5835):267-9. PubMed ID: 4563456
[TBL] [Abstract][Full Text] [Related]
38. Unusual osteoblastic metastases from carcinoid tumors.
Peavy PW; Rogers JV; Clements JL; Burns JB
Radiology; 1973 May; 107(2):327-30. PubMed ID: 4695897
[No Abstract] [Full Text] [Related]
39. [Treatment of Paget's disease with synthetic human calcitonin (author's transl)].
Gerschpacher H; Schindler H
Wien Klin Wochenschr; 1980 Aug; 92(15):535-8. PubMed ID: 6933743
[TBL] [Abstract][Full Text] [Related]
40. Paget's bone disease: response to human calcitonin in patients resistant to salmon calcitonin.
Rojanasathit S; Rosenberg E; Haddad JG
Lancet; 1974 Dec; 2(7894):1412-5. PubMed ID: 4140329
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
